Abemaciclib and Letrozole to Treat Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marilyn Huang, MD
University of Virginia
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of South Alabama Mitchell Cancer Center
Mobile, Alabama, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Smillow Cancer Care at Greenwich
Greenwich, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Sylvester Comprehensive Cancer Center-Lennar Foundation Medical Center
Coral Gables, Florida, United States
- Sylevester Comprehensive Cancer Center-Deerfield Beach
Deerfield Beach, Florida, United States
- Uf Health Cancer Center
Gainesville, Florida, United States
- Ut Health Tower
Miami, Florida, United States
- University of Miami - Sylvester Cancer Center
Miami, Florida, United States
- Advent Health - Orlando
Orlando, Florida, United States
- Sylvester Comprehensive Cancer Center-Plantation
Plantation, Florida, United States
- Cleveland Clinic Florida
Weston, Florida, United States
- Lewis Cancer & Research Pavilion
Savannah, Georgia, United States
- University of Chicago
Chicago, Illinois, United States
- Baptist Healthcare System
Lexington, Kentucky, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- University of Massachusetts
Worcester, Massachusetts, United States
- St. Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Holy Name Medical Center
Teaneck, New Jersey, United States
- Columbia University Medical Center
New York, New York, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Oklahoma Cancer Specialists and Research Institute
Tulsa, Oklahoma, United States
- Reading Hospital-Mcglinn Cancer Institute
Reading, Pennsylvania, United States
- Abington Memorial Hospital
Willow Grove, Pennsylvania, United States
- Baptist Health Center Lexington
Salt Lake City, Utah, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
- University of Virginia
Charlottesville, Virginia, United States
- West Virginia University
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Oct 2020
- Primary completion
- 1 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 9 Mar 2026
- Registered enrollment
- 53
- Registry id
- NCT04393285
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.